Aktuelle Standortbestimmung Der Konservativen Therapie Des Prostatakarzinoms 1989
DOI: 10.1515/9783110847390-014
|View full text |Cite
|
Sign up to set email alerts
|

Klinische Erfahrungen mit Cyproteronacetat als Monotherapie in der EORTC-Studie 30761

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles